Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate

Giuseppe Lopalco, Donato Rigante, Antonio Vitale, Bruno Frediani, Florenzo Iannone, Luca Cantarini
  • Clinical Rheumatology, March 2014, Springer Science + Business Media
  • DOI: 10.1007/s10067-014-2556-8

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Luca Cantarini

In partnership with: